Atividade Antiproliferativa de Benzaldeído Canfeno Tiossemicarbazonas em Células de Melanoma Humano (SK-MEL-37)

• Autor(a) principal: SOARES, Paula Roberta Otaviano
• Data de Publicação: 2008
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional da UFG
• dARK ID: ark:/38995/001300000858b
• Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tde/1274
• topic: Benzaldeído canfeno tiossemicarbazonas; melanoma; MTT; apoptose; citotoxicidade; 1.Melanoma humano(Câncer de pele); 2.Citoxidade; 3.Apoptose; Benzaldehyde camphene thiosemicarbazones; melanoma; in vitro; MTT; apoptosis; cytotoxicity; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA::BIOLOGIA MOLECULAR

The thiosemicarbazones are chemical compounds of considerable scientific interest due to their important biological properties, such as antitumoral, antibacterial, antiviral, and antiprotozoal, among others. The studied compounds have the natural monoterpene camphene in the R4 position and the benzaldehyde in R2, with the substitution in the ring for different (R) groups, making this work unique. In this way, thirteen different compounds were derived from the benzaldehyde camphene thiosemicarbazone: camphene isotyiocyanate, camphene thiosemicarbazide, benzaldehyde camphene thiosemicarbazone, p-metyl benzaldehyde camphene thiosemicarbazone, p-methoxy benzaldehyde camphene thiosemicarbazone, o-chloro benzaldehyde camphene thiosecarbazone, m-chloro benzaldehyde camphene thiosemicarbazone, p-chloro-benzaldehyde camphene thiosemicarbazone, o-nitrobenzaldehyde camphene thiosemicarbazone, m-nitro- benzaldehyde camphene thiosemicarbazone, p-nitrobenzaldehyde camphene thiosemicarbazone, p-dimetylamino benzaldehyde camphene thiosemicarbazone and p-hydroxy benzaldehyde camphene thiosemicarbazone. The experiments were conducted in vitro using human melanoma cells (SK-Mel-37), because the melanoma is the most serious type of skin cancer due to its high possibility to metastasize and its resistance to the induction of apoptosis by antineoplastic drugs. We first performed a visual screening to observe if there was detachment of more than 85% of the total number of cells, after treatment with the sole concentration of 100 μM. Thus, six compounds were selected: benzaldehyde camphene thiosemicarbazone, m-chloro benzaldehyde camphene thiosemicarbazone, m-nitro-benzaldehyde camphene thiosemicarbazone, p-dimetylamino benzaldehyde camphene thiosemicarbazone, p-hydroxy benzaldehyde camphene thiosemicarbazone e p-methoxy benzaldehyde camphene thiosemicarbazone. The morphological analysis of the treated cells, by inverted phase contrast microscope and Giemsa stain, showed intense cellular vacuolization and nuclear fragmentation. In the cellular viability test, through the MTT colorimetric assay, the compounds showed IC50 (inhibitory concentration for 50% of the cells) values between 12, 84 μM and 32, 18 μM, which are bellow of those described in the literature for compounds with antineoplastic action. The analysis of nuclear fragmentation by fluorescence microscopy was performed by the incorporation of propidium iodide, and it was observed, at different time points, a progressive increase of cellular damage and a pronounced nuclear fragmentation after the cellular detachment. The analysis of the DNA fragmentation by agarose gel electrophoresis revealed that the unequivocal cytotoxic action of the compounds occurred by apoptosis. Our results showed that six compounds derived from the benzaldehyde camphene thiosemicarbazones had cytotoxic activity in human melanoma cells (SK-Mel-37) in vitro, and constitute potential candidates for future analysis aiming its therapeutic application.